tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

Compare NewAmsterdam Pharma Company (NAMS) vs. Competitors

Compare
244 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
NewAmsterdam Pharma Company
$31.57
$3.53B
-15.46
41.63%
9 Buy
1 Hold
0 Sell
Strong Buy
Viking Therapeutics
$29.92
$3.28B
-14.13
-8.64%
6 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$41.45
$3.17B
-10.67
3.68%
13 Buy
0 Hold
0 Sell
Strong Buy
Soleno Therapeutics
$42.32
$2.07B
-22.98
-15.75%
9 Buy
0 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$44.67
$3.33B
99.62
127.91%
5 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$26.00
$5.24B
-9.22
19.96%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAMS
NewAmsterdam Pharma Company
31.57
10.45
49.48%
VKTX
Viking Therapeutics
29.92
-2.45
-7.57%
XENE
Xenon
41.45
1.47
3.68%
SLNO
Soleno Therapeutics
42.32
-7.46
-14.99%
KNSA
Kiniksa Pharmaceuticals
44.67
25.93
138.37%
IMVT
Immunovant
26.08
5.17
24.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts